Volato Reports First Quarter 2024 Results
Announces $14.5 Million in New Financing Grew Flight Hours 39% and Blended Yield 8% Year-over-Year Expect Delivery of 10-12 New Aircraft in FY 2024 ATLANTA–(BUSINESS... Read more.
Guerrilla RF Reports Record First Quarter 2024 Results and Gross Margin Expansion
Record revenue quarter of $5.1 million Gross Margin expands 640 basis points sequentially over prior quarter GREENSBORO, N.C.–(BUSINESS WIRE)–$GUER–Guerrilla... Read more.
Blackstone Life Sciences Launches Uniquity Bio to Develop Novel Medicines in Immunology & Inflammation
Blackstone Commits $300M in Financing Uniquity Bio Set to Start Phase 2 Clinical Trials in COPD & Asthma with Novel Anti-TSLP Monoclonal Antibody NEW YORK–(BUSINESS... Read more.
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
OSLO, Norway–(BUSINESS WIRE)–Oncoinvent AS, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced... Read more.
Castle Biosciences to Present at the Leerink Partners Healthcare Crossroads Conference
FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CastleBiosciences–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative... Read more.
Riskified Achieves Record Quarterly Free Cash Flows; Board Authorizes Additional $75 Million Share Repurchase Program
Improves 2024 Adjusted EBITDA Guidance NEW YORK–(BUSINESS WIRE)–Riskified Ltd. (NYSE: RSKD) (the “Company”), a leader in ecommerce fraud and risk... Read more.
Boréas Successfully Completes AEC-Q100 Grade 2 Automotive Qualification for BOS1211 Piezo Haptic Driver
–Third-generation haptics offer crisp tactile feedback to drivers, enhancing safety BROMONT, Québec–(BUSINESS WIRE)–#automotive—Boréas... Read more.
oceansix future paths Acquires Original RePack Oy
TEL AVIV, Israel–(BUSINESS WIRE)–oceansix future paths Ltd. (“oceansix” or the “Company”), a leader in advanced recycling and manufacturing technological... Read more.
Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
New Phase 3 data evaluating sacituzumab tirumotecan (sac-TMT), an investigational TROP2-directed antibody-drug conjugate, in previously treated locally recurrent... Read more.
Terran Orbital’s GEOStare SV2 Captures 3 Years of Success in High-Resolution Imaging
Terran Orbital and the Lawrence Livermore National Laboratory mission exceeds expectations, paving the way for future advancements in commercial satellite imagery... Read more.